Automation, digital lab and AI at EBF 2026

Nov 17–19, 2026 Barcelona, Spain ~800 attendees Website

10 organizations at EBF 2026 present work in automation, digital lab and AI: 6 drug developers and 4 CROs and suppliers. Between them they bring 23 presentations to the program. Most represented: Roche (9 on the program), Sanofi (5 on the program), GSK (4 on the program). 7 of them have their own page in this guide. As of Oct 13, 2026.

All 63 organizations at EBF 2026 →

Showing 1–10 of 10 organizations

Organization	EBF 2026 Attendance
Roche Basel, Switzerland
roche.com Pharma Pharmaceutical and diagnostics group developing medicines in oncology, immunology, neuroscience and ophthalmology, alongside its Roche Diagnostics business.	Talk Tue Nov 17 11:30–11:50am Part of Session 2: Smarter Workflows: From Implementation to Scientific Confidence Clinical Speed meets GLP Rigor: Upgrading an IVD Immunoanalyzer for High-Throughput PK/PD Analysis in a Bioanalytical Laboratory - Lessons Learnt Automation & AI · Ligand binding Talk Tue Nov 17 2:40–3pm Part of Session 5: Expanding LC–MS Bioanalysis: New Modalities, Advanced Workflows and Multi-Omics LC-MS Bioanalysis of Lipid Conjugated siRNAs: Analytical Challenges and Novel Approaches New modalities · LC–MS Talk Tue Nov 17 5:20–5:40pm Part of Session 7: BM CoU in practice Navigating Soluble Biomarker Complexity: Challenges, Assay Strategy, and Case Studies Biomarkers Talk Wed Nov 18 9–9:20am Part of Session 10: Bioanalysis Beyond Conventional Matrices From First-in-Human to Multi-Site Trials: Practical Bioanalytical Strategies to Preserve CSF Pharmacokinetic Data for Highly Adsorptive Molecules Sampling Talk Wed Nov 18 9:20–9:40am Part of Session 12: Assay life cycle Assay Lifecycle in Practice: Strategic Stewardship, Change Control, and Revalidation Case Studies Regulation Talk Wed Nov 18 9:40–10am Part of Session 10: Bioanalysis Beyond Conventional Matrices Operationalizing Unstable Biomarkers: How Biosample Operations and Bioanalysis Enable Successful Scale-Up from Single-Site to Multi-Site Clinical Trials Biomarkers · Sampling Talk Wed Nov 18 5–5:20pm Part of Workshop 10: ADA - Adaptive Tier Overcoming the 3-Tier ADA Testing Paradigm via Mechanistic Assay Understanding Immunogenicity Talk Thu Nov 19 9:20–9:40am Part of Session 16: Protein MS tech 1 A Multiplexed LC-MS/MS Strategy for the Simultaneous Quantification of a Transgene Protein and its Endogenous Counterpart in a Gene Therapy Program. LC–MS Talk Thu Nov 19 11:30–11:50am Part of Session 20: Pushing the Limits of Sensitivity and Multiplexing in Bioanalysis Navigating High-Plex Profiling and Targeted Quantification in Drug Development Biomarkers
Sanofi Paris, France
sanofi.com Pharma Pharmaceutical company developing medicines and vaccines in immunology, rare diseases, neurology and oncology.	Talk Wed Nov 18 12:10–12:30pm Part of Workshop 2: Emerging challenges in the e-environment Rethinking the Discovery Bioanalytical Dataflow using a Bespoke End-to-End Digital Solution Automation & AI Talk Wed Nov 18 12:20–12:40pm Part of Session 14: Rethinking ADA Assessment, Context, Evidence and Evolving Expectations - part 2 The Immunogenicity Nexus: Investigating the Predictive Relationship Between Early-Onset ADA Kinetics in NHP and Human Immune Responses Immunogenicity Talk Thu Nov 19 9–9:20am Part of Session 15: Flow From Raw Data to Insights in Minutes: Development of an Automated Flow Cytometry Data Pipeline for Preclinical Studies Cell-based · Automation & AI Talk Thu Nov 19 2–2:20pm Part of Session 21: Protein MS Tech 2 Generic Hybrid Immunocapture LC-MS/MS Approach for Integrity Assessment of Multispecific Antibodies in Clinical Studies: A Breakthrough Bioanalytical Strategy LC–MS · New modalities Talk Thu Nov 19 2:20–2:40pm Part of Session 21: Protein MS Tech 2 Advanced LC-MS Strategies for In Vivo Bioanalysis of Next-Generation Biotherapeutics: From Method Development to Multi-Therapeutic Area Applications LC–MS · New modalities
GSK London, UK
gsk.com Pharma Pharmaceutical company developing vaccines and medicines for infectious diseases, HIV, respiratory and immune-mediated diseases, and oncology.	Talk Tue Nov 17 12:10–12:30pm Part of Session 2: Smarter Workflows: From Implementation to Scientific Confidence Automation Innovations Drive Efficiencies in Flow Cytometry Clinical Sample Testing Automation & AI · Cell-based Talk Tue Nov 17 4:40–5pm Part of Session 8: Pharma CRO Lessons Learned During In-Licensing Talk Wed Nov 18 11:20–11:40am Part of Session 13: BioA Clinic It’s not your assay, it’s us: reappraising the CoU in response to extra-analytical factors Biomarkers Talk Thu Nov 19 9:40–10am Part of Session 15: Flow Operationalising high-parameter flow cytometry for large-scale clinical research Cell-based
LabWare Wilmington, Delaware	◇Sponsor
labware.com Instruments, reagents & softwareSponsor Makes LabWare LIMS and ELN laboratory informatics software.	Talk Wed Nov 18 11:30–11:50am Part of Workshop 2: Emerging challenges in the e-environment Maintaining Predictive Validity Across the Assay Lifecycle: When Method Revalidation Triggers Model Revalidation Automation & AI
up to data Wörrstadt, Germany	◇Sponsor
uptodata.com Instruments, reagents & softwareSponsor Lab-informatics firm that implements LIMS and study-data software for regulated laboratories.	Talk Wed Nov 18 11:50am–12:10pm Part of Workshop 2: Emerging challenges in the e-environment Generative AI in Regulated Bioanalytical Reporting: A Two-Layer Validation Architecture for GxP-Compliant Deployment Automation & AI · Regulation
Genmab Copenhagen, Denmark
genmab.com Biotech Antibody biotech developing bispecific antibodies and antibody–drug conjugates for cancer.	Talk Tue Nov 17 11:10–11:30am Part of Session 2: Smarter Workflows: From Implementation to Scientific Confidence Implementation of an End-to-End Automated Bioanalysis Workflow Automation & AI
Johnson & Johnson Innovative Medicine
jnj.com Pharma Johnson & Johnson's pharmaceutical business, formerly Janssen.	Talk Tue Nov 17 4:40–5pm Part of Session 9: New technologies and emerging modalities in Bioanalysis: PCR Automating qPCR Workflow: Investigation and Resolution of Over-Recovery from Low-Copy Numbers During Workflow Development PCR · Automation & AI
Regeneron Tarrytown, New York
regeneron.com Biotech Biotech developing antibody medicines for eye disease, inflammatory diseases, cancer and rare diseases.	Talk Tue Nov 17 12:30–12:50pm Part of Session 2: Smarter Workflows: From Implementation to Scientific Confidence One Well, Full Confidence: Automation-Enabled Singlicate Analysis for Regulated Bioanalysis Automation & AI
Alchemi	◇Sponsor
alchemi.bio Instruments, reagents & softwareSponsor AI platform whose agents draft and review regulated drug-development documents, such as study reports, for pharma, biotech and CRO teams.	Sponsor In the meeting’s sponsor directory, with no session on the public program
Sapio Sciences	◇Sponsor
sapiosciences.com Instruments, reagents & softwareSponsor Makes a lab informatics platform combining LIMS, electronic lab notebook and scientific data management.	Sponsor In the meeting’s sponsor directory, with no session on the public program